GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Pozycja w akcjach
#3775
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Cena akcji
$25.73
Kapitalizacja rynkowa
$4.36B
Zmiana (1 dzień)
-5.33%
Zmiana (1 rok)
-17.92%
Kraj
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategoria
Healthcare
Historia ceny akcji dla GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Najwyższa cena zamknięcia: $28.33 dnia 2026-10-01
Najniższa cena zamknięcia: $7.46 dnia 1999-01-01
Najniższa cena zamknięcia: $7.46 dnia 1999-01-01
Historia cen akcji firmy GlaxoSmithKline Pharmaceuticals Limited od 1999 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -0.80% |
| 2025 | 3.53% |
| 2024 | 30.13% |
| 2023 | 28.84% |
| 2022 | -31.26% |
| 2021 | 11.05% |
| 2020 | -8.11% |
| 2019 | 15.01% |
| 2018 | 5.68% |
| 2017 | -5.61% |
| 2016 | -18.58% |
| 2015 | 0.11% |
| 2014 | 11.37% |
| 2013 | 16.93% |
| 2012 | 5.11% |
| 2011 | -25.99% |
| 2010 | 39.42% |
| 2009 | 47.96% |
| 2008 | -8.92% |
| 2007 | -0.02% |
| 2006 | 7.37% |
| 2005 | 41.03% |
| 2004 | 38.71% |
| 2003 | 85.99% |
| 2002 | 3.08% |
| 2001 | -33.62% |
| 2000 | -42.61% |
| 1999 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $1.31K | 61.37% |
US
|
|
| $266.87 | 38.32% |
US
|
|
| $283.08 | 23.79% |
US
|
|
| $147.40 | 68.25% |
US
|
|
| $482.01 | 30.76% |
CH
|
